Large-scale testing (Phase 3)UnknownNCT00474591
What this trial is testing
Fondaparinux to Prevent Thrombotic Complications and Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery: The Fonda CABG Study
Who this might be right for
Coronary Bypass Graft Failure/Occlusion
Hamilton Health Sciences Corporation 100